Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Facial injectables Market– Insights
Facial injectables aid in rejuvenating facial skin by reducing or eliminating wrinkles, raising scar depressions, and enhancing lips. Facial injectables are products that include collagen fillers, hyaluronic acid fillers, and synthetic fillers such as calcium hydroxyl apatite. The use of injectable products such as hyaluronic acid increase skin hydration, improve skin, and protect from UV damage and has less side effects. These factors are expected to drive the market growth over the forecast years. Moreover, increasing demand for products that enhance personal beauty, rising consciousness about aesthetics, introduction of cost-effective facial injectables, and growing inclination towards minimally invasive procedures is expected to fuel the market growth.
The global facial injectables market was valued at US$ 5,088.5 million in 2019, and is expected to witness a CAGR of 14.9% over the forecast period (2019 – 2027).
Global Facial Injectables Market Share (%) Analysis, By Product Type, 2019
Source: Coherent Market Insights Analysis (2019)
Rising Demand for Facial Injectables to Enhance Aesthetic Beauty Is Expected To Drive Growth of The Global Facial Injectables Market.
Aesthetic procedure uses minimally invasive cosmetic procedures to improve the appearance. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS) in 2015, more than 20 million aesthetic procedures were performed globally. The demand for minimally invasive cosmetic procedures has led to an increase in demand for cosmetic products. In emerging economies, aesthetic medicine is gaining significant traction as people consider it as a part of a normal health treatment owing to the need to maintain a natural and healthy appearance.
Moreover, increasing promotional activities, rapidly developing healthcare infrastructure, and rising disposable income of the population are some of the factors that are expected to propel the facial injectables market growth. For instance, according to the American Society for Aesthetic Plastic Surgery (ASAPS), in 2016, people in the U.S. spent over US$ 15 billion on combined surgical and non-surgical aesthetic procedures, accounting for an 11% increase during 2015. Out of this, non-surgical procedures accounted for 44% of the total procedural spending.
Facial injectables Market- Restraints
The side effects associated with dermal injectables are expected to hinder growth of the facial injectables market during the forecast period. For instance, the healthcare practitioner’s injection technique can also determine whether the patient develops bruising and swelling. Rapid injection of fillers, use of the fanning technique, as well as using large volumes of fillers, have shown to increase incidence of bruising and swelling. Moreover, in some instances, if the filler has been injected too superficially, then it will cause a bluish discolouration of the skin overlying the filler.
Facial injectables Market- Regional Insights
On the basis of region, the global facial injectables market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global facial injectables market over the forecast period. Increasing regulatory approvals of facial injectables have spurred the growth of the market. For instance, in December 2016, Galderma S.A received the U.S. Food and Drug Administration’s approval for two new products ‘Restylane and Refyne’ for the treatment of nasolabial folds (NLF) or laugh lines in patients aged 21. Refyne was approved for the treatment of facial wrinkles and folds, while Restylane Defyne was approved for the treatment of moderate to severe, deep facial wrinkles and folds.
Asia Pacific is expected to witness rapid growth in the global facial injectables market over the forecast period. The market in Asia Pacific is expected to gain momentum owing to new product launches. For instance, in 2017, Lsf Farma Ltd launched three products in the filler range to alter the dermal skin tissues in the India market.
Global Facial injectables Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2027
Source: Coherent Market Insights Analysis (2019)
Facial injectables Market- Competitive Landscape
Key players operating in the global facial injectables market include Allergan plc, Galderma S.A., Medytox Inc., SciVision Biotech Inc., Croma-Pharma GmbH, Anika Therapeutics, Inc., Merz Pharmaceuticals, Sinclair Pharma plc, Suneva Medical, Inc. and Zimmer MedizinSysteme GmbH.